Commure vs Suki
If your failure mode is buying an enterprise scribe without deciding which direction the note should flow, this pair is the fork. Both are model first and both sell sales led enterprise contracts with no published price, so the choice is not price or ambience quality. Commure pushes the note downstream into the revenue cycle: ambient documentation feeds autonomous coding, clinical documentation integrity, and claims automation, a stack for a system that wants one contract from encounter to bill. Suki pushes the note sideways into the clinical workflow: a voice command layer over the EHR that stages orders, navigates charts, and answers questions against the specific patient record, with deep bidirectional integrations across five major systems. Pick by where you want the leverage, billing or bedside.
- The note becomes revenue: ambient documentation flows into autonomous coding, CDI, and claims automation, so the leverage lands in the revenue cycle rather than at the point of order entry.
- Reach is broad across more than 50 EHRs including Epic, Oracle Health, and MEDITECH, ambulatory and acute, with a January 2025 Vizient contract giving member systems negotiated access.
- Human oversight is a purchasable structure across Go, Assist, and Live, useful for a system standardizing documentation policy across many service lines.
- The command layer is the difference: clinicians issue voice commands to order medications, navigate charts, stage orders for review, and query the record, which a passive scribe cannot do.
- The deepest EHR surface in this pair: bidirectional integrations across Epic, Oracle Health, athenahealth, MEDITECH, and Elation, plus a Platform that lets other software vendors embed the capability.
- The autonomy ceiling is set sensibly: voice commands stage orders for clinician review rather than submitting them, keeping a human decision between the model and any clinical action.
Side-by-Side
| Axis | C Commure |
S Suki |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | — | — |
| Clinical and Operational Evidence | — | — |
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | — | |
| Security Certifications and Trust Center | — | |
| FDA and Regulatory Status | — | — |
| AI Governance and Bias Disclosure | — | — |
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | — | |
| Commercial Transparency | ||
| Setting and Specialty Coverage | — |
Neither vendor publishes pricing, so both are recorded as contact the vendor and left ungraded on commercial transparency; third party listings place Suki near 299 to 399 dollars per provider a month, the most expensive scribe in the lane by estimate, while Commure's enterprise pricing is undisclosed. Suki's command interpretation accuracy and its escalation behavior when a command is misheard are not published, which matters more than a note error because a misinterpreted medication order carries higher consequence. Commure's grid is vendor published across nine axes with no independent clinical evidence assessed, and its SOC 2 Type 2 reference attaches to its data centers rather than to Commure itself.